← Back to headlines
Canada Approves First Generic Version of Novo's Ozempic
Canada has officially approved the first generic version of Novo Nordisk's popular diabetes drug, Ozempic. This approval is expected to introduce a more affordable alternative to the market.
29 Apr, 15:14 — 29 Apr, 15:14
Sources
Showing 1 of 2 sources
Coverage Timeline
First report: capital-bg · 29 Apr, 09:47|Full coverage: 2 · 5h|Window: 5h
Left-leaningCenterRight-leaning
Related Stories
Nvidia Beats Earnings Expectations and Forecasts 70% Growth, Lifting Tech Stocks
31m ago
Nvidia Reportedly Agrees to Acquire Open-Source AI Firm Hugging Face
38m ago
OpenAI Detects Coordinated Cyberattack by Hundreds of Autonomous AI Agents
43m ago
Bill Gates Warns of AI Job Disruption, Proposes Policy Safeguards
59m ago